A

Arcturus Therapeutics Holdings

D
ARCT
USD
0.49
(2.3833%)
Market Closed
25,266.00
Volume
-2.995
EPS
-
Div Yield
-7.825279
P/E
569,239,278.30
Market Cap
Today
2.3833%
1 Week
5.726%
1 Month
-1.636%
6 Months
-37.611%
12 Months
-24.498%
Year To Date
-33.026%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
8.85235E-5
(0.2311%)
USD

Title:
Arcturus Therapeutics Holdings

Sector:
Healthcare
Industry:
Biotechnology
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.
Do you need help or have a question?
Contact Us